Medios AG (ILM1) - Net Assets
Based on the latest financial reports, Medios AG (ILM1) has net assets worth €519.70 Million EUR (≈ $607.58 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€918.23 Million ≈ $1.07 Billion USD) and total liabilities (€398.53 Million ≈ $465.92 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore ILM1 asset base for the complete picture of this company's asset base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €519.70 Million |
| % of Total Assets | 56.6% |
| Annual Growth Rate | 30.37% |
| 5-Year Change | 30.46% |
| 10-Year Change | 1408.04% |
| Growth Volatility | 2602.14 |
Medios AG - Net Assets Trend (2009–2025)
This chart illustrates how Medios AG's net assets have evolved over time, based on quarterly financial data. Check Medios AG tangible equity quality to evaluate the tangible quality of the company's equity base.
Annual Net Assets for Medios AG (2009–2025)
The table below shows the annual net assets of Medios AG from 2009 to 2025. For live valuation and market cap data, see how much is Medios AG worth.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | €514.22 Million ≈ $601.18 Million |
+0.79% |
| 2024-12-31 | €510.19 Million ≈ $596.47 Million |
+8.83% |
| 2023-12-31 | €468.81 Million ≈ $548.08 Million |
+4.63% |
| 2022-12-31 | €448.05 Million ≈ $523.81 Million |
+13.67% |
| 2021-12-31 | €394.16 Million ≈ $460.82 Million |
+176.75% |
| 2020-12-31 | €142.43 Million ≈ $166.51 Million |
+74.48% |
| 2019-12-31 | €81.63 Million ≈ $95.43 Million |
+15.79% |
| 2018-12-31 | €70.50 Million ≈ $82.42 Million |
+54.34% |
| 2017-12-31 | €45.68 Million ≈ $53.40 Million |
+33.95% |
| 2016-12-31 | €34.10 Million ≈ $39.86 Million |
+10431.51% |
| 2015-12-31 | €323.78K ≈ $378.53K |
-- |
| 2014-12-31 | €0.00 ≈ $0.00 |
-- |
| 2013-12-31 | €7.81K ≈ $9.13K |
-95.49% |
| 2012-12-31 | €172.97K ≈ $202.22K |
-54.09% |
| 2011-12-31 | €376.75K ≈ $440.46K |
+10.46% |
| 2010-12-31 | €341.07K ≈ $398.75K |
-95.38% |
| 2009-12-31 | €7.38 Million ≈ $8.63 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Medios AG's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 9376800000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €93.77 Million | 18.24% |
| Common Stock | €25.51 Million | 4.96% |
| Other Components | €394.94 Million | 76.80% |
| Total Equity | €514.22 Million | 100.00% |
Medios AG Competitors by Market Cap
The table below lists competitors of Medios AG ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
G Willi-Food International Ltd
TA:WILC
|
$312.24 Million |
|
Bhansali Engineering Polymers Limited
NSE:BEPL
|
$312.25 Million |
|
Oponeo.pl SA
WAR:OPN
|
$312.32 Million |
|
Precious Shipping Public Company Limited
BK:PSL-R
|
$312.37 Million |
|
FSP Technology Inc
TW:3015
|
$312.10 Million |
|
Perpetual Credit Income Trust
AU:PCI
|
$312.08 Million |
|
Nano Dimension Ltd
NASDAQ:NNDM
|
$311.98 Million |
|
Zhejiang Double Arrow Rubber Co Ltd
SHE:002381
|
$311.97 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Medios AG's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 510,192,000 to 514,219,000, a change of 4,027,000 (0.8%).
- Net income of 15,365,000 contributed positively to equity growth.
- Share repurchases of 12,580,000 reduced equity.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €15.37 Million | +2.99% |
| Share Repurchases | €12.58 Million | -2.45% |
| Other Changes | €1.24 Million | +0.24% |
| Total Change | €- | 0.79% |
Book Value vs Market Value Analysis
This analysis compares Medios AG's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.53x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 14.67x to 0.53x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2010-12-31 | €0.75 | €10.98 | x |
| 2011-12-31 | €0.83 | €10.98 | x |
| 2012-12-31 | €0.41 | €10.98 | x |
| 2013-12-31 | €0.02 | €10.98 | x |
| 2015-12-31 | €0.71 | €10.98 | x |
| 2016-12-31 | €7.38 | €10.98 | x |
| 2017-12-31 | €3.58 | €10.98 | x |
| 2018-12-31 | €5.00 | €10.98 | x |
| 2019-12-31 | €5.47 | €10.98 | x |
| 2020-12-31 | €8.90 | €10.98 | x |
| 2021-12-31 | €19.55 | €10.98 | x |
| 2022-12-31 | €18.77 | €10.98 | x |
| 2023-12-31 | €19.69 | €10.98 | x |
| 2024-12-31 | €20.88 | €10.98 | x |
| 2025-12-31 | €20.53 | €10.98 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Medios AG utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 2.99%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.74%
- • Asset Turnover: 2.30x
- • Equity Multiplier: 1.76x
- Recent ROE (2.99%) is above the historical average (-159.34%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2011 | 16.01% | 4.39% | 2.09x | 1.75x | €22.64K |
| 2012 | -117.82% | -578.54% | 0.08x | 2.55x | €-221.08K |
| 2013 | -2115.86% | -50645.54% | 0.00x | 30.02x | €-165.94K |
| 2015 | -49.68% | -119388.59% | 0.00x | 1.57x | €-193.24K |
| 2016 | -9.87% | -2.38% | 2.78x | 1.49x | €-6.38 Million |
| 2017 | 9.05% | 1.63% | 4.11x | 1.35x | €-433.32K |
| 2018 | 6.14% | 1.32% | 3.33x | 1.40x | €-2.72 Million |
| 2019 | 11.96% | 1.89% | 4.43x | 1.43x | €1.60 Million |
| 2020 | 3.88% | 0.88% | 3.22x | 1.37x | €-8.72 Million |
| 2021 | 1.88% | 0.55% | 2.59x | 1.33x | €-32.01 Million |
| 2022 | 4.09% | 1.14% | 2.80x | 1.29x | €-26.48 Million |
| 2023 | 4.01% | 1.05% | 3.00x | 1.27x | €-28.07 Million |
| 2024 | 2.46% | 0.67% | 2.02x | 1.83x | €-38.47 Million |
| 2025 | 2.99% | 0.74% | 2.30x | 1.76x | €-36.06 Million |
Industry Comparison
This section compares Medios AG's net assets metrics with peer companies in the Medical Distribution industry.
Industry Context
- Industry: Medical Distribution
- Average net assets among peers: $168,257,048
- Average return on equity (ROE) among peers: -13.08%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Medios AG (ILM1) | €519.70 Million | 16.01% | 0.77x | $312.19 Million |
| AKSO HEALTH GR. (SPADR)/3 (8HX) | $12.29 Million | -137.16% | 4.11x | $1.60 Billion |
| EDAP TMS S.A (EDA) | $27.36 Million | 5.53% | 0.94x | $128.94 Million |
| Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (GU5) | $7.92 Billion | 15.07% | 0.80x | $439.62 Million |
| CLOUDR GROUP LTD. (H3L) | $-7.16 Billion | 0.00% | 0.00x | $36.61 Million |
| M1 Kliniken AG (M12) | $115.32 Million | 5.92% | 0.64x | $300.08 Million |
| Paragon Care Limited (PXS) | $20.58 Million | 10.22% | 0.97x | $123.85 Million |
| Sigma Healthcare Limited (S5YA) | $476.74 Million | -2.59% | 1.54x | $19.74 Billion |
| TELES Informationstechnologien AG (TLIK) | $55.51 Million | 20.17% | 0.56x | $1.49 Million |
| COSMOS HEALTH NEW DL-01 (V67A) | $39.66 Million | -34.88% | 0.72x | $10.60 Million |
About Medios AG
Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. It operates through three segments: Patient-Specific Therapies; International Business; and Pharmaceutical Supply. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies. This segment also includes cytostatic preparations, antibody therapies, and p… Read more